First Trust Direct Indexing’s Novartis NVS Stock Holding History

First Trust Direct Indexing’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,769	Closed	-$2.62M	–	622
2024 Q3	$2.62M	Buy	22,769 +128	+0.6%	+$14.5K	0.14%	144
2024 Q2	$2.41M	Buy	22,641 +1,513	+7%	+$152K	0.15%	127
2024 Q1	$2.04M	Buy	21,128 +568	+3%	+$58.2K	0.15%	139
2023 Q4	$2.08M	Buy	20,560 +1,974	+11%	+$191K	0.19%	117
2023 Q3	$1.89M	Buy	18,586 +1,941	+12%	+$197K	0.22%	106
2023 Q2	$1.68M	Buy	16,645 +1,717	+12%	+$172K	0.19%	118
2023 Q1	$1.37M	Buy	14,928 +576	+4%	+$50.3K	0.16%	149
2022 Q4	$1.3M	Sell	14,352 -12,556	-47%	-$1.06M	0.17%	145
2022 Q3	$2.04M	Buy	26,908 +1,284	+5%	+$106K	0.3%	62
2022 Q2	$2.17M	Buy	25,624 +13,997	+120%	+$1.23M	0.3%	68
2022 Q1	$1.02M	Buy	11,627 +3,746	+48%	+$324K	0.12%	207
2021 Q4	$689K	Sell	7,881 -102	-1%	-$8.47K	0.09%	281
2021 Q3	$653K	Sell	7,983 -69	-0.9%	-$6.21K	0.09%	274
2021 Q2	$735K	Buy	+8,052	New	+$717K	0.11%	243
2021 Q1	–	Sell	-445	Closed	-$42K	–	785
2020 Q4	$42K	Buy	+445	New	+$38.9K	0.01%	790

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

First Trust Direct Indexing's NVS Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Novartis (NVS) in Q4 2024, closing a stake of 22,769 shares — an estimated $2.62M sold.

First Trust Direct Indexing first reported a position in NVS in Q4 2020 and held it in 15 quarters. The position peaked at $2.62M in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

First Trust Direct Indexing reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
First Trust Direct Indexing sold 22,769 Novartis shares in Q4 2024, an estimated $2.62M.
First Trust Direct Indexing first reported a position in Novartis in Q4 2020 and held it in 15 quarters.
First Trust Direct Indexing's Novartis position peaked at $2.62M in Q3 2024.
1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.